文献
J-GLOBAL ID:201702290251152210
整理番号:17A1717680
テロメア長肝細胞癌リスクとの遺伝的関連:メンデル無作為化解析【Powered by NICT】
Genetic association of telomere length with hepatocellular carcinoma risk: A Mendelian randomization analysis
著者 (17件):
Cheng Yue
(Department of Epidemiology and Biostatistics, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center For Cancer Personalized Medicine, School of Public Health, Nanjing Medical University, Nanjing 211166, China)
,
Yu Chengxiao
(Department of Epidemiology and Biostatistics, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center For Cancer Personalized Medicine, School of Public Health, Nanjing Medical University, Nanjing 211166, China)
,
Huang Mingtao
(Department of Epidemiology and Biostatistics, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center For Cancer Personalized Medicine, School of Public Health, Nanjing Medical University, Nanjing 211166, China)
,
Du Fangzhi
(Department of Epidemiology and Biostatistics, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center For Cancer Personalized Medicine, School of Public Health, Nanjing Medical University, Nanjing 211166, China)
,
Song Ci
(Department of Epidemiology and Biostatistics, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center For Cancer Personalized Medicine, School of Public Health, Nanjing Medical University, Nanjing 211166, China)
,
Ma Zijian
(Department of Epidemiology and Biostatistics, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center For Cancer Personalized Medicine, School of Public Health, Nanjing Medical University, Nanjing 211166, China)
,
Zhai Xiangjun
(Department of Infectious Diseases, Jiangsu Province Center for Disease Prevention and Control, Nanjing, China)
,
Yang Yuan
(Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China)
,
Liu Jibin
(Tumor Biobank, Nantong Tumor Hospital, Nantong, China)
,
Bei Jin-Xin
(Department of Hepatobiliary Oncology, State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangzhou, China)
,
Jia Weihua
(Department of Hepatobiliary Oncology, State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangzhou, China)
,
Jin Guangfu
(Department of Epidemiology and Biostatistics, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center For Cancer Personalized Medicine, School of Public Health, Nanjing Medical University, Nanjing 211166, China)
,
Li Shengping
(Department of Hepatobiliary Oncology, State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangzhou, China)
,
Zhou Weiping
(Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China)
,
Liu Jianjun
(Department of Human Genetics, Genome Institute of Singapore, A*STAR, Singapore, Singapore)
,
Dai Juncheng
(Department of Epidemiology and Biostatistics, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center For Cancer Personalized Medicine, School of Public Health, Nanjing Medical University, Nanjing 211166, China)
,
Hu Zhibin
(Department of Epidemiology and Biostatistics, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center For Cancer Personalized Medicine, School of Public Health, Nanjing Medical University, Nanjing 211166, China)
資料名:
Cancer Epidemiology
(Cancer Epidemiology)
巻:
50
号:
PA
ページ:
39-45
発行年:
2017年
JST資料番号:
T0010A
ISSN:
1877-7821
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)